RIGL
Rigel Pharmaceuticals
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Market Cap: 274 Million
Primary Exchange: NASDAQ
Website: https://www.rigel.com/
Shares Outstanding: 175 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.9398586433889229
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 2349 trading days
From: 2013-03-06 To: 2024-03-07
Lowest Point:
Rigel to Present Two Posters Highlighting Fostamatinib at the 24?? Congress of the European Hematology Association (EHA)
via: PR Newswire at 2019-06-13 03:30:00:000
SOUTH SAN FRANCISCO , June 13, 2019 /PRNewswire/ --Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will present data on fostamatinib disodium hexahydrate (fostamatinib) in two posters at the 24 th Congress of the European Hematology Association (EHA) in Amsterda… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|